Clinical Trial Update: The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated metformin as an adjuvant therapy in relapsing-remitting multiple sclerosis patients in Egypt, focusing on immunological paramete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: German University in Cairo | Conditions: Multiple Sclerosis (MS) - Relapsing-remitting | Phase 2 | Status: COMPLETED